TrialPloS one2026

A phase III double-blind, placebo-controlled, randomized withdrawal trial of 5‑aminolevulinic acid hydrochloride with sodium ferrous citrate for efficacy and safety in patients diagnosed as Leigh syndrome.

Akira Ohtake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.